News Release Details

AMETEK Announces Fourth Quarter 2016 Results

February 7, 2017 at 6:46 AM EST
PDF Version

BERWYN, Pa., Feb. 7, 2017 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced its financial results for the three month and full year periods ended December 31, 2016. 

AMETEK reported fourth quarter 2016 sales of $973.0 million, down 1.5% from last year's fourth quarter.  On a GAAP basis, fourth quarter 2016 operating income was $173.2 million and diluted earnings per share were $0.47.  Excluding adjustments of $39.5 million, or $0.11 per diluted share, fourth quarter 2016 operating income was $212.7 million and diluted earnings per share were $0.58.  A reconciliation of reported GAAP results to adjusted results is included in the financial tables accompanying this release and on the AMETEK website.

"I am very pleased with our team's performance during 2016 in what was a challenging global macro environment.  As we had anticipated, business conditions stabilized and we delivered solid results in the fourth quarter that were in-line with our expectations," said David A. Zapico, AMETEK Chief Executive Officer. 

"Cash flow was excellent in the quarter, with operating cash flow of $247 million, a 24% increase over the same period of 2015 and at a record level," added Mr. Zapico.   

Electronic Instruments Group (EIG)
In the fourth quarter 2016, EIG sales decreased 2% to $616.0 million, compared with the fourth quarter of 2015.  On a GAAP basis, EIG operating income was $141.1 million in the 2016 fourth quarter.  Excluding fourth quarter 2016 adjustments, operating income was $162.6 million.      

"EIG sales were positively impacted by the acquisitions of Brookfield, ESP/SurgeX, Nu Instruments, and HS Foils.  In addition, our Ultra Precision Technologies business had another solid quarter to complete an excellent year.  Although year-over-year sales across our oil and gas businesses were down, those businesses performed in-line with expectations," commented Mr. Zapico. 

Electromechanical Group (EMG)
In the fourth quarter of 2016, EMG sales decreased 1% to $356.9 million, compared with the fourth quarter of 2015.  On a GAAP basis, fourth quarter 2016 EMG operating income was $46.7 million.  Excluding fourth quarter 2016 adjustments, EMG operating income was $63.0 million.

"Overall EMG sales were down slightly in the quarter driven by foreign currency headwinds, while organic sales were roughly flat versus the prior year.  Our Engineered Materials, Interconnects and Packaging businesses have stabilized as we had anticipated," noted Mr. Zapico.

2017 Outlook       
"We are confident as we enter 2017 as we are well positioned to generate solid earnings growth.  Our most challenging end markets have stabilized.  We have taken realignment actions during the fourth quarter to better position our cost structure and we continue to see positive results from the implementation of our Four Growth Strategies," commented Mr. Zapico.  

"We anticipate 2017 sales to be up mid-single digits versus 2016, with organic sales up low-single digits.  We initiate our 2017 earnings guidance in the range of $2.34 to $2.46 per diluted share, up 2% to 7% percent, compared with 2016 adjusted earnings of $2.30 per diluted share," he added. 

"We expect first quarter 2017 sales to be roughly flat versus last year's first quarter and estimate our earnings to be approximately $0.55 to $0.57 per diluted share," concluded Mr. Zapico.

Conference Call
AMETEK will webcast its fourth quarter 2016 investor conference call on Tuesday, February 7, 2017, beginning at 8:30 AM ET.  The live audio webcast will be available at the Investors section of www.ametek.com and at www.streetevents.com.  The call also will be archived at the Investors section of www.ametek.com.

Corporate Profile
AMETEK is a leading global manufacturer of electronic instruments and electromechanical devices with annual sales of approximately $4.0 billion.  AMETEK's Corporate Growth Plan is based on Four Key Strategies: Operational Excellence, Strategic Acquisitions, Global & Market Expansion and New Products. AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. The common stock of AMETEK is a component of the S&P 500 Index.  

Forward-looking Information
Statements in this news release relating to future events, such as AMETEK's expected business and financial performance are "forward-looking statements."  Forward-looking statements are subject to various factors and uncertainties that may cause actual results to differ significantly from expectations. These factors and uncertainties include AMETEK's ability to consummate and successfully integrate future acquisitions; risks associated with international sales and operations; AMETEK's ability to successfully develop new products, open new facilities or transfer product lines; the price and availability of raw materials; compliance with government regulations, including environmental regulations; changes in the competitive environment or the effects of competition in our markets; the ability to maintain adequate liquidity and financing sources; and general economic conditions affecting the industries we serve.  A detailed discussion of these and other factors that may affect our future results is contained in AMETEK's filings with the U.S. Securities and Exchange Commission, including its most recent reports on Form 10-K, 10-Q and 8-K.  AMETEK disclaims any intention or obligation to update or revise any forward-looking statements.

(Financial Information Follows)


 


AMETEK, Inc.

Consolidated Statement of Income

(In thousands, except per share amounts)


 Three Months Ended 

 Year Ended 

 December 31, 

 December 31, 

2016

2015

2016

2015

 (Unaudited) 

 (Unaudited) 

 (Unaudited) 

Net sales

$   972,953

$   987,983

$3,840,087

$3,974,295

Operating expenses:






     Cost of sales

681,084

666,263

2,575,220

2,617,987

     Selling, general and administrative

118,647

112,890

462,970

448,592

          Total operating expenses 

799,731

779,153

3,038,190

3,066,579








Operating income 

173,222

208,830

801,897

907,716

Other expenses:






     Interest expense

(23,588)

(22,747)

(94,304)

(91,795)

     Other, net

(4,382)

(3,243)

(14,490)

(9,541)

Income before income taxes

145,252

182,840

693,103

806,380

Provision for income taxes

36,144

45,999

180,945

215,521








Net income

$   109,108

$   136,841

$   512,158

$   590,859








Diluted earnings per share

$        0.47

$        0.57

$        2.19

$        2.45

Basic earnings per share

$        0.47

$        0.58

$        2.20

$        2.46








Weighted average common shares outstanding:






     Diluted shares

231,191

238,689

233,730

241,586

     Basic shares

230,209

237,220

232,593

239,906








Dividends per share

$        0.09

$        0.09

$        0.36

$        0.36








 

 

AMETEK, Inc.

Information by Business Segment

(In thousands)


 Three Months Ended 

 Year Ended 

 December 31, 

 December 31, 

2016

2015

2016

2015

 (Unaudited) 

 (Unaudited) 

 (Unaudited) 

Net sales:






     Electronic Instruments

$   616,039

$   628,415

$2,360,285

$2,417,192

     Electromechanical

356,914

359,568

1,479,802

1,557,103

          Consolidated net sales

$   972,953

$   987,983

$3,840,087

$3,974,295








Income:






Segment operating income:






     Electronic Instruments

$   141,075

$   161,659

$   577,717

$   639,399

     Electromechanical

46,692

60,169

277,873

318,098

          Total segment operating income

187,767

221,828

855,590

957,497

     Corporate administrative and other expenses

(14,545)

(12,998)

(53,693)

(49,781)

          Consolidated operating income

$   173,222

$   208,830

$   801,897

$   907,716








 

 

AMETEK, Inc.

Condensed Consolidated Balance Sheet

(In thousands)


 December 31, 

 December 31, 

2016

2015

 (Unaudited) 

ASSETS


Current assets:


     Cash and cash equivalents

$             717,259

$            381,005

     Receivables, net

592,326

603,295

     Inventories, net

492,104

514,451

     Other current assets

126,501

120,076

          Total current assets

1,928,190

1,618,827




Property, plant and equipment, net

473,230

484,548

Goodwill

2,818,950

2,706,633

Other intangibles, investments and other assets

1,880,304

1,850,442

          Total assets

$          7,100,674

$         6,660,450




LIABILITIES AND STOCKHOLDERS' EQUITY


Current liabilities:


     Short-term borrowings and current portion of long-term debt, net

$             278,921

$            384,924

     Accounts payable and accruals

645,520

639,097

          Total current liabilities

924,441

1,024,021




Long-term debt, net

2,062,644

1,553,116

Deferred income taxes and other long-term liabilities

857,076

828,687

Stockholders' equity

3,256,513

3,254,626

          Total liabilities and stockholders' equity

$          7,100,674

$         6,660,450




 

 

AMETEK, Inc.

Reconciliations of GAAP to Non-GAAP Financial Measures

(In thousands, except per share amounts)

(Unaudited)














Three Months Ended

Year Ended



December 31,

December 31,



2016

2015

2016

2015











EIG Segment operating income (GAAP)

$ 141,075

$ 161,659

$ 577,717

$ 639,399

Realignment costs

12,355

9,267

12,355

18,518

Indefinite-lived intangibles impairment

9,200

-

9,200

-

Adjusted EIG Segment operating income (Non-GAAP)

$ 162,630

$ 170,926

$ 599,272

$ 657,917











EMG Segment operating income (GAAP)

$   46,692

$   60,169

$ 277,873

$ 318,098

Realignment costs

11,644

10,764

11,644

17,298

Indefinite-lived intangibles impairment

4,700

-

4,700

-

Adjusted EMG Segment operating income (Non-GAAP)

$   63,036

$   70,933

$ 294,217

$ 335,396











Operating income (GAAP)

$ 173,222

$ 208,830

$ 801,897

$ 907,716

Realignment costs

25,556

20,711

25,556

36,605

Indefinite-lived intangibles impairment

13,900

-

13,900

-

Adjusted Operating income (Non-GAAP)

$ 212,678

$ 229,541

$ 841,353

$ 944,321











Net income (GAAP)

$ 109,108

$ 136,841

$ 512,158

$ 590,859

Realignment costs

25,556

20,711

25,556

36,605

Income tax benefit on realignment costs

(8,578)

(6,843)

(8,578)

(11,929)

Indefinite-lived intangibles impairment

13,900

-

13,900

-

Income tax benefit on indefinite-lived intangibles impairment

(5,310)

-

(5,310)

-

Adjusted Net income (Non-GAAP)

$ 134,676

$ 150,709

$ 537,726

$ 615,535











Diluted earnings per share (GAAP)

$      0.47

$      0.57

$      2.19

$      2.45

Realignment costs

0.11

0.09

0.11

0.15

Income tax benefit on realignment costs

(0.04)

(0.03)

(0.04)

(0.05)

Indefinite-lived intangibles impairment

0.06

-

0.06

-

Income tax benefit on indefinite-lived intangibles impairment

(0.02)

-

(0.02)

-

Adjusted Diluted earnings per share (Non-GAAP)

$      0.58

$      0.63

$      2.30

$      2.55











EIG Segment operating margin (GAAP)

22.9%

25.7%

24.5%

26.5%

Realignment costs

2.0

1.5

0.5

0.7

Indefinite-lived intangibles impairment

1.5

-

0.4

-

Adjusted EIG Segment operating margin (Non-GAAP)

26.4%

27.2%

25.4%

27.2%











EMG Segment operating margin (GAAP)

13.1%

16.7%

18.8%

20.4%

Realignment costs

3.3

3.0

0.8

1.1

Indefinite-lived intangibles impairment

1.3

-

0.3

-

Adjusted EMG Segment operating margin (Non-GAAP)

17.7%

19.7%

19.9%

21.5%











Operating income margin (GAAP)

17.8%

21.1%

20.9%

22.8%

Realignment costs

2.6

2.1

0.7

1.0

Indefinite-lived intangibles impairment

1.5

-

0.3

-

Adjusted Operating income margin (Non-GAAP)

21.9%

23.2%

21.9%

23.8%











Effective tax rate (GAAP)

24.9%

25.2%

26.1%

26.7%

Realignment costs

1.4

0.8

0.3

0.3

Indefinite-lived intangibles impairment

0.8

-

0.2

-

Adjusted Effective tax rate (Non-GAAP)

27.1%

26.0%

26.6%

27.0%











Use of Non-GAAP Financial Information
 
The Company supplements its consolidated financial statements presented on a U.S. generally accepted accounting principles ("GAAP") basis with certain non‑GAAP financial information to provide investors with greater insight, increased transparency and allow for a more comprehensive understanding of the information used by management in its financial and operational decision-making.  Reconciliation of non‑GAAP measures to their most directly comparable GAAP measures are included in the accompanying financial tables. These non‑GAAP financial measures should be considered in addition to, and not as a replacement for, or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies.
 
The Company believes that these measures provide useful information to investors by reflecting additional ways of viewing AMETEK's operations that, when reconciled to the comparable GAAP measure, helps our investors to better understand the long-term profitability trends of our business, and facilitates easier comparisons of our profitability to prior and future periods and to our peers.  The items described above have been excluded from this measure because items of this nature and/or size occur with inconsistent frequency, occur for reasons that may be unrelated to AMETEK's commercial performance during the period and/or we believe are not indicative of AMETEK's ongoing operating costs or gains in a given period, which we believe may obscure underlying business trends and make comparisons of long-term performance difficult.

 

Contact: Kevin Coleman 610-889-5247

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ametek-announces-fourth-quarter-2016-results-300403279.html

SOURCE AMETEK, Inc.